129 related articles for article (PubMed ID: 21986170)
41. Detection of human telomerase RNA gene in cervical cancer and precancerous lesions: comparison with cytological and human papillomavirus DNA test findings.
Li Y; Ye F; Lü WG; Zeng WJ; Wei LH; Xie X
Int J Gynecol Cancer; 2010 May; 20(4):631-7. PubMed ID: 20686384
[TBL] [Abstract][Full Text] [Related]
42. Experience with 40,000 Papanicolaou smears.
Sandmire HF; Austin SD; Bechtel RC
Obstet Gynecol; 1976 Jul; 48(1):56-60. PubMed ID: 934574
[TBL] [Abstract][Full Text] [Related]
43. Screening histories of women with CIN 2/3 compared with women diagnosed with invasive cervical cancer: a retrospective analysis of the Norwegian Coordinated Cervical Cancer Screening Program.
Nygård JF; Nygård M; Skare GB; Thoresen SØ
Cancer Causes Control; 2005 May; 16(4):463-74. PubMed ID: 15953989
[TBL] [Abstract][Full Text] [Related]
44. HPV detection rates and histopathologic follow-up of patients with HSIL cytology in a large academic women's hospital laboratory.
Ashman D; Zhang H; Li J; Austin M; Wang T; Pradhan D; Zhao C
J Am Soc Cytopathol; 2020; 9(6):550-555. PubMed ID: 32475726
[TBL] [Abstract][Full Text] [Related]
45. [ThinPrep liquid-based cervical cytology: a retrospective analysis of 50,340 cases].
Ma AG; Li Y; He QZ; Ye JL; Lu HJ
Zhonghua Bing Li Xue Za Zhi; 2009 Feb; 38(2):127-8. PubMed ID: 19573361
[No Abstract] [Full Text] [Related]
46. Human papillomavirus deoxyribonucleic acid detection in mildly or moderately dysplastic smears: a possible method for selecting patients for colposcopy.
Bollen LJ; Tjong-A-Hung SP; van der Velden J; Brouwer K; Mol BW; ten Kate FJ; ter Schegget J
Am J Obstet Gynecol; 1997 Sep; 177(3):548-53. PubMed ID: 9322622
[TBL] [Abstract][Full Text] [Related]
47. Cytological & colposcopic evaluation in premalignant & early malignant lesions of the cervix.
Singh V; Verma K; Bhargava VL
Indian J Med Res; 1983 Jul; 78 Suppl():54-9. PubMed ID: 6654431
[No Abstract] [Full Text] [Related]
48. Human papillomavirus types 16 and 18 mRNA levels and not DNA levels may be associated with advancing stages of cervical cancer.
Gnanamony M; Peedicayil A; Subhashini J; Ram TS; Christopher S; Gravitt P; Abraham P
Int J Gynecol Cancer; 2009 Nov; 19(8):1415-20. PubMed ID: 20009900
[TBL] [Abstract][Full Text] [Related]
49. Value of colposcopy in the early diagnosis of cervical cancer in patients with abnormal pap smears at Shahid Sadoughi hospital, Yazd.
Karimi Zarchi M; Binesh F; Kazemi Z; Teimoori S; Soltani HR; Chiti Z
Asian Pac J Cancer Prev; 2011; 12(12):3439-41. PubMed ID: 22471494
[TBL] [Abstract][Full Text] [Related]
50. Study protocol of the CHOiCE trial: a three-armed, randomized, controlled trial of home-based HPV self-sampling for non-participants in an organized cervical cancer screening program.
Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B
BMC Cancer; 2016 Nov; 16(1):835. PubMed ID: 27809810
[TBL] [Abstract][Full Text] [Related]
51. How predictive is a cervical smear suggesting invasive squamous cell carcinoma?
Johnson SJ; Wadehra V
Cytopathology; 2001 Jun; 12(3):144-50. PubMed ID: 11380555
[TBL] [Abstract][Full Text] [Related]
52. [HPV-Hr detection by home self sampling in women not compliant with pap test for cervical cancer screening. Results of a pilot programme in Bouches-du-Rhône].
Piana L; Leandri FX; Le Retraite L; Heid P; Tamalet C; Sancho-Garnier H
Bull Cancer; 2011 Jul; 98(7):723-31. PubMed ID: 21700548
[TBL] [Abstract][Full Text] [Related]
53. Achievable laboratory standards; a review of cytology of 99 women with cervical cancer.
Womack C; Warren AY
Cytopathology; 1998 Jun; 9(3):171-7. PubMed ID: 9638378
[TBL] [Abstract][Full Text] [Related]
54. Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive disease.
Macgregor JE; Campbell MK; Mann EM; Swanson KY
BMJ; 1994 May; 308(6941):1407-11. PubMed ID: 8019250
[TBL] [Abstract][Full Text] [Related]
55. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
56. Application of human papillomavirus in screening for cervical cancer and precancerous lesions.
Wang JL; Yang YZ; Dong WW; Sun J; Tao HT; Li RX; Hu Y
Asian Pac J Cancer Prev; 2013; 14(5):2979-82. PubMed ID: 23803065
[TBL] [Abstract][Full Text] [Related]
57. Human papillomavirus load and genotype analysis improves the prediction of invasive cervical cancer.
Hortlund M; van Mol T; Van de Pol F; Bogers J; Dillner J
Int J Cancer; 2021 Aug; 149(3):684-691. PubMed ID: 33586149
[TBL] [Abstract][Full Text] [Related]
58. Impact of opportunistic screening on squamous cell and adenocarcinoma of the cervix in Germany: A population-based case-control study.
Tanaka LF; Schriefer D; Radde K; Schauberger G; Klug SJ
PLoS One; 2021; 16(7):e0253801. PubMed ID: 34260601
[TBL] [Abstract][Full Text] [Related]
59. Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden.
Wang J; Andrae B; Sundström K; Ploner A; Ström P; Elfström KM; Dillner J; Sparén P
PLoS Med; 2017 Oct; 14(10):e1002414. PubMed ID: 29065127
[TBL] [Abstract][Full Text] [Related]
60. Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV Study.
Flores Y; Shah K; Lazcano E; Hernández M; Bishai D; Ferris DG; Lörincz A; Hernández P; Salmerón J;
Salud Publica Mex; 2002; 44(4):335-44. PubMed ID: 12216521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
